-
Cost-Substitution and Hospital Diagnosis-Related Group (DRG) Performance Impact Analysis of Infliximab Biosimilar Adoption in Moderate-to-Severe Crohn's Disease Patients in China
Sep 9, 2025, 16:22 PM -
The PHEBUS Study: A Retrospective Analysis of the Burden of Pneumococcal Infections in the Pediatric Population Using the French Hospital Discharge Database (PMSI)
Sep 9, 2025, 16:22 PM -
What Makes a Medicine Innovative? A Literature Review of Evaluation Frameworks
Sep 9, 2025, 16:22 PM -
The Cost of Complacency: Projecting the Burden of HIV Care in Eight European Countries
Sep 9, 2025, 16:22 PM -
Defining Decision-Making Criteria for Glaucoma Surgery in Non-Refractory, Moderate to Severe Open-Angle Glaucoma: A Stakeholder Analysis Across Multiple Countries with Distinct Payer Archetypes to Support a Multi-Criteria Decision Analysis Framework
Sep 9, 2025, 16:22 PM -
The Economic Case for Gender Equity: How Closing the Women’s Health Gap Benefits Healthcare Systems and Economies
Sep 9, 2025, 16:22 PM -
Model Behavior: A Health Economics Checklist for Sales Models
Sep 9, 2025, 16:22 PM -
Improving Patient Involvement in Cancer Clinical Trials: Development of Plain Language Checklists Within the SISAQOL-IMI Initiative
Sep 9, 2025, 16:22 PM -
Cost Utility of Subcutaneous Methotrexate As a Second-Line Treatment for Moderate to Severe Rheumatoid Arthritis in the UK
Sep 9, 2025, 16:22 PM -
From Evidence to Enforcement? Implications of the 2025 SVR Report for Pharmaceutical Pricing and Orphan Drug Policy in Germany
Sep 9, 2025, 16:22 PM -
Mapping of Treatment Patterns and Transfusion Status in Danish and Swedish Myelofibrosis (MF) Patients
Sep 9, 2025, 16:22 PM -
Development of a Discrete Choice Experiment to Explore Preferences for Self-Sampling in a National UK Cervical Screening Program
Sep 9, 2025, 16:22 PM -
The Evolving Role of Pharmacists as Vaccinators in New Zealand and Denmark
Sep 9, 2025, 16:22 PM -
Assessment of Health State Utilities Associated With Treatment for Chronic Hepatitis B Virus (HBV) Infection
Sep 9, 2025, 16:22 PM -
Evaluating AI Chatbot Empathy and Probing Skills in Automated Patient In-Trial Interviews: A Proof of Principle Experiment
Sep 9, 2025, 16:22 PM -
Unlocking the Value of RSV Adult Vaccination With Adjuvanted RSVpreF3 Vaccine in Spain: A Return on Investment Analysis Using an Integrated Actuarial Macroeconomic Model
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of Linzagolix 200 mg Plus Add-back Therapy (Linzagolix+ABT) for Symptomatic Treatment of Endometriosis
Sep 9, 2025, 16:22 PM -
HTA Readiness for Tumor-Agnostic Therapies: Lessons From Analogues Across Major Markets
Sep 9, 2025, 16:22 PM -
US Population-Level Clinical Impact of Lorlatinib Treatment on ALK+ Metastatic Non-Small Cell Lung Cancer Outcomes
Sep 9, 2025, 16:22 PM -
Is NICE’s Proportionate Approach Achieving Its Objective: Analysis of Time to Access for Cost Comparison vs. Single Technology Appraisal
Sep 9, 2025, 16:22 PM
